The FDA just announced an important DSCSA update for small independent pharmacies.
If your pharmacy has 25 or fewer full-time pharmacists and pharmacy technicians, the FDA is asking you to complete its Small Dispenser Assessment by September 22, 2026: Small Dispensers Assessment >
A consultant can also complete the assessment on your behalf. The goal of the assessment is to help the FDA understand whether the technology required for package-level tracing is practical and accessible for smaller pharmacies.
What this means for independent pharmacies:
- Qualifying small dispensers have an extension on certain DSCSA requirements until November 27, 2027.
- More time doesn’t mean compliance efforts should pause. Use the extension to adopt solutions that already exist and make compliance seamless for your pharmacy.
- MatchRX has built-in DSCSA compliance, so nothing changes with how you operate. Through our partnership with LSPedia, members can maintain the same workflow with automatic DSCSA compliance for $49.95, compared with the standard $150 retail rate: Claim MatchRX Member Pricing >
The extension gives independent pharmacies more time to prepare—not a reason to wait. Use that time to put the right solutions in place now so compliance becomes part of your everyday workflow, not another task to manage later.
We’ll continue sharing updates as they happen and helping independent pharmacies stay ahead of what’s next.
FDA’s Assessment Announcement: Find here >
FDA Exemption Information: Find here >
FDA’s Assessment: Find here >
